Arrowhead Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2025
Total Assets: $1.39B
Liabilities Breakdown FY2025
Total Liabilities: $919.2M
Asset Breakdown
Total Assets: $1.39B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $226.5M | 16.4% |
| Accounts Receivable | $6.8M | 0.5% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $382.5M | 27.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $6.9M | 0.5% |
| Other Assets | $762.5M | 55.0% |
Liabilities Breakdown
Total Liabilities: $919.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $17.7M | 1.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $901.6M | 98.1% |